Colgate-Palmolive (CL) Insider Sells $68,389.64 in Stock

Colgate-Palmolive (NYSE:CL) insider Jennifer Daniels sold 902 shares of Colgate-Palmolive stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $75.82, for a total transaction of $68,389.64. Following the transaction, the insider now directly owns 37,788 shares in the company, valued at $2,865,086.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Jennifer Daniels also recently made the following trade(s):

  • On Wednesday, December 13th, Jennifer Daniels sold 7,375 shares of Colgate-Palmolive stock. The stock was sold at an average price of $73.18, for a total transaction of $539,702.50.

Shares of Colgate-Palmolive (CL) opened at $74.62 on Friday. The company has a debt-to-equity ratio of 24.42, a current ratio of 1.23 and a quick ratio of 0.92. Colgate-Palmolive has a 52 week low of $63.43 and a 52 week high of $77.27. The stock has a market cap of $65,462.75, a price-to-earnings ratio of 28.81, a price-to-earnings-growth ratio of 3.15 and a beta of 0.80.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The firm had revenue of $3.97 billion for the quarter, compared to analyst estimates of $3.94 billion. During the same period in the previous year, the business earned $0.73 EPS. The company’s revenue was up 2.8% compared to the same quarter last year. equities research analysts anticipate that Colgate-Palmolive will post 2.88 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, February 15th. Shareholders of record on Tuesday, January 23rd will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 2.14%. Colgate-Palmolive’s payout ratio is currently 61.78%.

CL has been the topic of several research reports. Citigroup cut their price objective on shares of Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating on the stock in a research report on Thursday, November 2nd. Zacks Investment Research raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 price objective on the stock in a research report on Monday, October 23rd. KeyCorp reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research report on Saturday, November 25th. Macquarie raised shares of Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price objective on the stock in a research report on Tuesday, December 19th. Finally, SunTrust Banks raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and boosted their price objective for the company from $65.00 to $85.00 in a research report on Wednesday, October 11th. Two research analysts have rated the stock with a sell rating, thirteen have given a hold rating and six have given a buy rating to the company’s stock. Colgate-Palmolive currently has a consensus rating of “Hold” and a consensus target price of $76.51.

Hedge funds have recently modified their holdings of the business. Pacer Advisors Inc. increased its stake in Colgate-Palmolive by 8.4% in the 2nd quarter. Pacer Advisors Inc. now owns 20,224 shares of the company’s stock valued at $1,499,000 after buying an additional 1,566 shares during the last quarter. Fiduciary Trust Co. increased its stake in shares of Colgate-Palmolive by 1.6% during the 2nd quarter. Fiduciary Trust Co. now owns 170,818 shares of the company’s stock worth $12,663,000 after purchasing an additional 2,758 shares during the last quarter. The Manufacturers Life Insurance Company increased its stake in shares of Colgate-Palmolive by 10.3% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,131,987 shares of the company’s stock worth $83,914,000 after purchasing an additional 105,878 shares during the last quarter. Pensionfund DSM Netherlands acquired a new position in shares of Colgate-Palmolive during the 3rd quarter worth about $4,225,000. Finally, Pacad Investment Ltd. acquired a new position in shares of Colgate-Palmolive during the 2nd quarter worth about $549,000. Hedge funds and other institutional investors own 72.83% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by Stock Observer and is the sole property of of Stock Observer. If you are accessing this report on another domain, it was illegally copied and reposted in violation of US & international copyright & trademark law. The correct version of this report can be accessed at https://www.thestockobserver.com/2018/01/13/colgate-palmolive-cl-insider-sells-68389-64-in-stock.html.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply